Albert Dyrness is the Divisional President, Life Sciences. This pillar provides engineering and compliance solutions to the life science industry. Albert has more than 20 years of experience in process engineering design, and commissioning of GMP equipment, systems, and facilities.

Albert is a member of the American Society of Mechanical Engineers Bioprocess Equipment (ASME BPE) Standards Committee and is serving as the Chairperson for the ASME BPE System Design subcommittee. He is a past board member of Oncobiologics (now Outlook Therapeutics), a NASDAQ-traded clinical stage biopharmaceutical company. He is also an Industrial Advisory Board Member of the University of the Pacific?s Bioengineering program.

Albert received an M.S. in Mechanical Engineering from Massachusetts Institute of Technology. He holds professional engineering licenses in the state of California for Chemical Engineering and Mechanical Engineering.